The basket is empty
"The executive team ... believes that the most value-creating strategy for AstraZeneca is to remain a focused, integrated, innovation-driven, global, prescription-based biopharmaceutical business."
Find out more
AstraZeneca Annual Report and Form 20-F Information 2009 English (PDF 7Mb) Swedish (PDF 1.9Mb)
Visit the Download centre